Massimo Iacobelli

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

Journal: European journal of haematology

Published: February 26, 2026

Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.

Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.

Journal: Biomolecules

Published: May 02, 2025

Comparison of sfilm-FS and TACHOSIL in patients undergoing liver surgical procedures requiring hemostasis - A phase 1/2, randomised, controlled study.

Comparison of sfilm-FS and TACHOSIL in patients undergoing liver surgical procedures requiring hemostasis - A phase 1/2, randomised, controlled study.

Journal: American journal of surgery

Published: February 10, 2025

Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide.

Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide.

Journal: Blood reviews

Published: May 01, 2024

Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control.

Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control.

Journal: Haematologica

Published: February 27, 2024

Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.

Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.

Journal: Expert opinion on therapeutic targets

Published: June 25, 2021

In vivo Skin Penetration, Radical Protection, and Structural Changes after Topical Application of a Herbal Oil Cream Compared to Topical Calcipotriol in Mild to Moderate Psoriasis.

In vivo Skin Penetration, Radical Protection, and Structural Changes after Topical Application of a Herbal Oil Cream Compared to Topical Calcipotriol in Mild to Moderate Psoriasis.

Journal: Skin pharmacology and physiology

Published: May 20, 2021

Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy.

Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy.

Journal: EJHaem

Published: February 10, 2021

Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?"

Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?"

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 12, 2020

COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.

COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.

Journal: British journal of haematology

Published: July 23, 2020

A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting.

A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: July 21, 2020

Response to the Letter to the Editor by Eshghi P et al.

Response to the Letter to the Editor by Eshghi P et al.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: December 30, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026